Moreover, knockdown of Smad4 promoted the expression of β-catenin, while the treatment with CD55-Smad4 downregulated the expression of β-catenin, vimentin, and N-cadherin in CRC cells, while the expression of E-cadherin was upregulated (Figure 4D). Here, SMAD4 is linked to colorectal carcinoma.